Fiscal Year: April - March
McKesson Corporation (MCK), listed on the NYSE, has a market capitalization of $98.48B. As of Jul 17, 2026, the stock is trading at $841.12 per share@else an unavailable price , offering investors a clear view of its current market value. McKesson Corporation is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 21.92, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. McKesson Corporation also offers a dividend yield of 0.39%, making it an attractive option for income-focused investors who seek regular dividends.
DCF analysis data is not yet available for McKesson Corporation (MCK). The fair value estimate will be displayed once sufficient analyst forecast data is collected.
The proprietary SS Score for McKesson Corporation is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for McKesson Corporation, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for McKesson Corporation is 17.26, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, McKesson Corporation (MCK) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether McKesson Corporation (MCK) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. It is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of McKesson Corporation (MCK) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of McKesson Corporation. To access the full SS Score, consider upgrading your subscription.
McKesson Corporation is a significant player in the industry sector, with a market capitalization of $98.48B and a competitive P/E ratio of 21.92. Investors should compare these metrics with industry peers to gauge whether McKesson Corporation is outperforming or underperforming within its sector.
McKesson stock gained on Wednesday and one Wall Street analysts expects the shares to continue to rally.
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a l...
IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson Corporation hosted McKesson ideaShare 2026, the company's annual event for independent community pharmacies, in Denver, Colorado.
Barclays lowered the firm’s price target on McKesson (MCK) to $925 from $1,050 and keeps an Overweight rating on the shares. The firm updated estimates and targets in the drug…
McKesson (MCK) announced the successful completion of the previously announced minority ownership interest investment from funds managed by affiliates of Apollo (APO) in McKesson’s Medical-Surgical So...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by affi...
Citi lowered the firm’s price target on McKesson (MCK) to $945 from $975 and keeps a Buy rating on the shares.
UBS analyst Kevin Caliendo raised the firm’s price target on McKesson (MCK) to $1,050 from $1,000 and keeps a Buy rating on the shares. Despite the “messy” Q4 print, the…
Evercore ISI lowered the firm’s price target on McKesson (MCK) to $850 from $950 and keeps an Outperform rating on the shares.
Baird analyst Eric Coldwell lowered the firm’s price target on McKesson (MCK) to $941 from $1,010 and keeps an Outperform rating on the shares. The firm updated its model following…
Deutsche Bank analyst George Hill lowered the firm’s price target on McKesson (MCK) to $875 from $973 and keeps a Buy rating on the shares.
JPMorgan lowered the firm’s price target on McKesson (MCK) to $1,015 from $1,107 and keeps an Overweight rating on the shares.
BofA analyst Allen Lutz lowered the firm’s price target on McKesson (MCK) to $900 from $1,000 and keeps a Buy rating on the shares. McKesson reported “a mixed quarter,” but…
Notable companies reporting after the market close, with earnings consensus, include Gilead (GILD), consensus $1.91… Mckesson (MCK), consensus $11.57… Cloudflare (NET), consensus 23c… Airbnb (ABNB), c...
McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates on Thursday, as the U.S. drug distributor banks on strength in its oncology and spe...
Reports Q4 revenue $96.3B, consensus $101.4B.
Sees Fy27 revenue up 5%-9%, implying $423.6B-$439.7B, consensus $442.44B.
16:15 EDT McKesson (MCK) down 2% at $737 after Q4 results and FY27 guide
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
